Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × copanlisib × 1 year × Clear all

Sponsor

Conditions

Neoplasm Metastasis 5 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma 3 Breast Neoplasms 3 Ovarian Neoplasms 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Endometrial Neoplasms 2 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Spinocerebellar Degenerations 1 Neoplasms 1 Mycosis Fungoides 1 Metastatic Castration-resistant Prostate Cancer 1 Malignant Solid Neoplasm 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 Disease Progression 1 Colonic Neoplasms 1

Interventions

Cyclophosphamide 11 Prednisone 8 Doxorubicin 8 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 Vincristine 6 Brentuximab Vedotin 5 Azacitidine 5 fludarabine 4 Gemcitabine 4 Etoposide 4 romidepsin 3 pembrolizumab 3 belinostat 3 Dexamethasone 3 Biopsy 3 10-propargyl-10-deazaaminopterin 3 tazemetostat 2 ruxolitinib 2 Lenalidomide 2 Bendamustine Hydrochloride 2 venetoclax 1 tislelizumab 1 tipifarnib 1 thymoglobulin 1 sodium-iodide symporter 1 selinexor 1 relatlimab 1 pomalidomide 1 ixazomib 1 ivarmacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡